Hypophysitis induced by ipilimumab and nivolumab combination therapy for advanced renal cell carcinoma: A case report

Ipilimumab and nivolumab combination therapy is effective against unresectable or metastatic renal cell carcinoma. However, it is associated with many immune-related adverse events, including hypophysitis that is difficult to diagnose early because of non-specific initial symptoms. Herein, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Motonaga, Aoi, Nakanishi, Shotaro, Tanaka, Kei, Nishida, Sho, Izumi, Keiichiro, Saito, Seiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040277/
https://www.ncbi.nlm.nih.gov/pubmed/33868946
http://dx.doi.org/10.1016/j.eucr.2021.101661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040277/
https://www.ncbi.nlm.nih.gov/pubmed/33868946
http://dx.doi.org/10.1016/j.eucr.2021.101661

Ejemplares similares